Amgen competitors & alternatives

Amgen Inc. is a global leader in the biopharmaceutical industry, specializing in the discovery, development, and manufacturing of human therapeutics for serious illnesses. As a pioneer in biotechnology, the company leverages advanced molecular biology and biochemistry to produce complex biologics. Professionals and stakeholders often search for competitors and alternatives to Amgen to evaluate market positioning, therapeutic pipeline strength, and manufacturing capabilities. Comparing Amgen against other industry giants helps investors and partners understand the landscape of high-value drug development, patent protection strategies, and the competitive dynamics of the global biopharmaceutical manufacturing sector.

Top Amgen competitors

Amgen competitors include Genentech, AbbVie, Gilead Sciences, Biogen and Regeneron.

12 Alternatives

Genentech

Biotechnology Research and ManufacturingEnterprise

Genentech competes with Amgen in the development of complex monoclonal antibodies and oncology therapeutics. While Amgen focuses on large-scale global manufacturing infrastructure, Genentech emphasizes early-stage clinical innovation and personalized medicine. Buyers often choose Genentech for its deep integration with Roche’s global diagnostic capabilities and specialized oncology research pipeline.

AbbVie

Biopharmaceutical DevelopmentEnterprise

AbbVie competes with Amgen in the immunology and rheumatology markets, particularly with high-value biologics. Unlike Amgen’s diversified portfolio across nephrology and bone health, AbbVie maintains a concentrated focus on blockbuster immunology franchises. Buyers may prefer AbbVie for its aggressive commercial execution and specialized expertise in managing chronic autoimmune conditions.

Gilead Sciences

Biopharmaceutical InnovationEnterprise

Gilead Sciences competes with Amgen in the development of high-impact specialty medicines, specifically in virology and oncology. While Amgen leverages a massive manufacturing footprint for biologics, Gilead focuses on small-molecule innovation and targeted viral therapies. Buyers choose Gilead for its leadership in curative treatments and highly focused therapeutic area expertise.

Biogen

Neurology-Focused BiopharmaceuticalsEnterprise

Biogen competes with Amgen in the production of complex protein-based therapies, with a specific niche in neurological disorders. Unlike Amgen’s broad-spectrum approach to chronic disease management, Biogen specializes in high-barrier-to-entry neuroscience research. Buyers often select Biogen for its deep clinical focus on multiple sclerosis and Alzheimer’s disease treatment pathways.

Regeneron

Biotechnology and Drug DiscoveryEnterprise

Regeneron competes with Amgen in the development of advanced antibody-based therapies. While Amgen utilizes established, large-scale manufacturing processes, Regeneron is known for its proprietary VelociSuite technologies that accelerate drug discovery. Buyers choose Regeneron for its rapid R&D cycle and ability to bring novel, genetically-validated targets to market faster than traditional manufacturers.

Unlock Full Company Details and Decision-Maker Insights

Tech stack categories related to Amgen

These categories group common types of tools used across the tech stack, helping organize platforms by their core capabilities.

Biologic Drug Manufacturing

Large-scale production of complex protein-based therapeutic agents.

Monoclonal Antibody Development

Research and engineering of targeted antibody therapies.

Specialty Therapeutic Pipelines

Development of high-value drugs for chronic conditions.

Market overview

The biopharmaceutical market is defined by intense competition in R&D innovation and the ability to scale complex manufacturing processes for global distribution. Key decision factors include therapeutic efficacy, patent longevity, and the ability to navigate stringent regulatory environments across international markets. Explore Amgen’s funding and financial details.

Why users choose Amgen

  • Proven track record in large-scale biologics manufacturing
  • Extensive global supply chain and distribution network
  • Strong portfolio of established chronic disease therapies
  • Significant investment in next-generation drug discovery

Why users switch to alternatives

  • Higher agility in early-stage clinical research
  • More specialized focus on niche therapeutic areas
  • Proprietary drug discovery platforms that accelerate timelines
  • Different pricing models for emerging market access

Discover competitor landscapes for other companies

Axess
Financial Payment SolutionsEnterprise

Axess is a prominent financial service platform specializing in credit card issuing, installment-based shopping, and merchant payment solutions. As a key player in the Turkish banking sector, it provides consumers and businesses with flexible payment tools and loyalty rewards. Users frequently search for competitors and alternatives to Axess when seeking more specialized fintech integrations, lower merchant transaction fees, or more agile digital payment processing capabilities. Comparing Axess against other market leaders helps businesses and consumers identify the right financial infrastructure to support their specific transaction needs, whether they prioritize traditional banking stability or modern, developer-centric payment APIs.

Ammega
Industrial Belting SolutionsEnterprise

Ammega Group is a leading global manufacturer of industrial belting and fluid power solutions, providing critical components for manufacturing, logistics, and food processing. As businesses seek to optimize their production lines and reduce downtime, they often compare Ammega Group against other specialized industrial manufacturers. Whether you are looking for high-performance conveyor belts, power transmission systems, or specialized rubber components, understanding the competitive landscape is essential. This guide explores the top competitors and alternatives to Ammega Group, helping you evaluate which provider best aligns with your specific operational requirements, technical specifications, and supply chain needs in the global industrial market.

China Power International Development
Power Generation UtilityEnterprise

China Power International Development Ltd is a prominent power generation company focused on the development, construction, and operation of clean energy projects, including hydro, wind, and solar power. As the energy sector undergoes a rapid transition toward decarbonization, stakeholders frequently compare China Power with other major utility providers to evaluate portfolio resilience, renewable energy capacity, and long-term growth potential. Whether you are analyzing market alternatives for investment or operational benchmarking, understanding how China Power stacks up against its peers in terms of energy mix, regional reach, and technological innovation is essential for navigating the competitive landscape of the Chinese power generation industry.

Shuanglin Group
Automotive Parts ManufacturerEnterprise

Shuanglin is a prominent manufacturer specializing in automotive components, including interior systems, electronic parts, and mechanical assemblies. As the automotive industry shifts toward electrification and smart cabin design, businesses often compare Shuanglin against global competitors to evaluate manufacturing quality, supply chain reliability, and technological innovation. Whether you are looking for cost-effective production or advanced engineering partnerships, understanding the landscape of alternatives is essential. This guide helps you compare Shuanglin with industry leaders, highlighting key differences in product focus, global reach, and specialized manufacturing capabilities to ensure you select the right partner for your automotive supply chain requirements.

Hyundai Glovis
Global Logistics and Supply ChainEnterprise

Hyundai Glovis Co Ltd is a leading global logistics and supply chain management company, primarily known for its specialized automotive logistics, shipping, and distribution services. As a key player in the transportation sector, it is frequently evaluated against other global logistics competitors and alternatives that offer similar freight, warehousing, and supply chain integration capabilities. Businesses compare these providers to determine which partner offers the best balance of industry-specific expertise, global network reach, and cost-effective transport solutions. Understanding how Hyundai Glovis stacks up against these alternatives is essential for organizations looking to optimize their international shipping, inventory management, and complex supply chain workflows.

Rochling
High-Performance Plastics ManufacturerEnterprise

Röchling SE & Co. KG is a global leader in the manufacturing of high-performance plastics, providing customized components for the automotive, medical, and industrial sectors. As organizations seek to optimize material performance and supply chain reliability, they often compare Röchling against other specialized engineering plastics manufacturers. Whether evaluating material durability, precision machining capabilities, or industry-specific compliance, professionals look for alternatives that offer comparable technical expertise. This analysis explores the top competitors and alternatives to Röchling, helping stakeholders identify the best partners for their specific engineering and manufacturing requirements in the competitive global plastics market.

Frequently Asked Questions About Amgen Competitors

Who are the main competitors of Amgen?
The main competitors of Amgen include Genentech, AbbVie, and Gilead Sciences. Each competitor links to its company profile page.
What are some alternatives to Amgen?
Alternatives to Amgen include companies such as Gilead Sciences, Biogen, and Regeneron.
Which companies compete with Amgen?
Other companies that compete with Amgen include Regeneron.